Glaukos Announces Participation in Wells Fargo Healthcare Conference
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal...
How might the market react to any unexpected negative news or lack of substantive updates from the conference?
Will the company address any recent clinical trial results or safety concerns that could affect market perception?
What potential regulatory milestones (e.g., FDA approvals) might be discussed that could impact the stock?
16 days ago